FUROSCIX DIRECT

Serial Number 97681853
Registration 7289009
700

Registration Progress

Application Filed
Nov 17, 2022
Under Examination
Jun 6, 2023
Approved for Publication
Apr 11, 2023
Published for Opposition
Apr 11, 2023
Registered
Jan 23, 2024

Trademark Image

FUROSCIX DIRECT

Basic Information

Serial Number
97681853
Registration Number
7289009
Filing Date
November 17, 2022
Registration Date
January 23, 2024
Published for Opposition
April 11, 2023
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Jan 23, 2024
Registration
Registered
Classes
035 036 039

Rights Holder

scPharmaceuticals Inc.

03
Address
25 Mall Road, Suite 203
Burlington, MA 01803

Ownership History

scPharmaceuticals Inc.

Original Applicant
03
Burlington, MA

scPharmaceuticals Inc.

Owner at Publication
03
Burlington, MA

scPharmaceuticals Inc.

Original Registrant
03
Burlington, MA

Legal Representation

Attorney
Julie Nichols Matthews

USPTO Deadlines

Next Deadline
1483 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20240123)
Due Date
January 23, 2030
Grace Period Ends
July 23, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

36 events
Date Code Type Description Documents
Dec 16, 2025 NURC C NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED Loading...
Nov 24, 2025 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Nov 22, 2025 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Oct 22, 2025 ES7R I TEAS SECTION 7 REQUEST RECEIVED Loading...
Dec 16, 2024 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 16, 2024 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 16, 2024 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 23, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Jan 23, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 16, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Dec 15, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Dec 15, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Dec 5, 2023 IUAF S USE AMENDMENT FILED Loading...
Dec 14, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Dec 7, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 5, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Dec 5, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 5, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 5, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 6, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 11, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 11, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 22, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 8, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 27, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 27, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 22, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 24, 2023 CEPE I COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED Loading...
Jan 24, 2023 ALIE A ASSIGNED TO LIE Loading...
Jan 23, 2023 GEAN O NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jan 23, 2023 GEAP F EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED Loading...
Jan 23, 2023 CPEA R EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED Loading...
Jan 13, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 9, 2022 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Dec 8, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 21, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 035
Business administration of medication reimbursement programs and services; Business administration of pharmacy reimbursement programs and services
First Use Anywhere: Feb 27, 2023
First Use in Commerce: Feb 27, 2023
Class 036
Financial administration of medication reimbursement programs and services; Financial administration of pharmacy reimbursement programs and services
First Use Anywhere: Feb 27, 2023
First Use in Commerce: Feb 27, 2023
Class 039
home delivery of medical products
First Use Anywhere: Feb 27, 2023
First Use in Commerce: Feb 27, 2023

Additional Information

Design Mark
The mark consists of the word "FUROSCIX" in larger font above the word "DIRECT" in smaller font together with a triangular shaped design.
Color Claim
Color is not claimed as a feature of the mark.
Other
In the statement, line 1, "scPharmaceuticals, Inc." and "Massachusetts " should be deleted, and "scPharmaceuticals Inc." and "Delaware" should be inserted.

Classification

International Classes
035 036 039

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"DIRECT"